|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017256,
umls-concept:C0032854,
umls-concept:C0035647,
umls-concept:C0038952,
umls-concept:C0302350,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C1140680,
umls-concept:C1332697,
umls-concept:C1521840,
umls-concept:C1552599,
umls-concept:C1561558,
umls-concept:C1704787
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-5-25
|
|
pubmed:abstractText |
This study examined the clinical significance of CCNE1 (Cyclin E1) amplification and assessed whether CCNE1 is a potential therapeutic target in ovarian cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2010 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2621-34
|
|
pubmed:meshHeading |
pubmed-meshheading:20336784-Cell Line, Tumor,
pubmed-meshheading:20336784-Cell Proliferation,
pubmed-meshheading:20336784-Cyclin E,
pubmed-meshheading:20336784-Disease-Free Survival,
pubmed-meshheading:20336784-Female,
pubmed-meshheading:20336784-Gene Amplification,
pubmed-meshheading:20336784-Gene Dosage,
pubmed-meshheading:20336784-Gene Knockdown Techniques,
pubmed-meshheading:20336784-Humans,
pubmed-meshheading:20336784-Middle Aged,
pubmed-meshheading:20336784-Oncogene Proteins,
pubmed-meshheading:20336784-Ovarian Neoplasms
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
